Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiaPep277 in Newly Diagnosed Type 1 Diabetes
NCT00615264Phase 3Completed
- Sponsor
- Andromeda Biotech Ltd.
- Start
- Sep 2005
- Primary completion
- Sep 2011
- Modality
- Peptides, Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of diapep277 in type 1 diabetes mellitus (T1D), sponsored by Andromeda Biotech Ltd.. Started Sep 2005; status: completed.
02
Drugs
diapep277
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00615264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615264.